| Market Size in 2023 | Market Forecast in 2032 | Growth Rate (in %) | Base Year |
|---|---|---|---|
| USD 48.39 Billion | USD 83.15 Billion | CAGR at 6.20% | 2023 |
Blood components preparation has a rising significance in the present age. It is a process in which one unit of whole blood goes through centrifugation. It is carried out in specialized equipment known as a refrigerated centrifuge. The whole blood is a mixture of crystalloids, cellular elements, and colloids of varying the relative size, density and sediment rate which can be separated by the application of centrifugal force.
The global blood preparation market is segmented into its product type, blood thinning agents, and geography.
On the basis of product type, the market is divided into blood components, whole blood, and blood derivatives. Blood components further include packed red cells, whole blood components, frozen plasma, leukocyte reduced red blood cells and platelet concentrate. Whole blood includes granulocytes, red cells, platelets, and plasma.
Based on blood thinning agents, the market is segregated into fibrinolytic, platelet aggregation inhibitor and anticoagulants.
On the basis of the region, diversification is seen into North America, Asia-Pacific, Europe, Latin America and the Middle East and Africa.
The blood preparation market is a growing market owing to factors such as increasing number of causalities in the hospital, increasing number of blood disorders and increasing need for blood during surgical procedures. Also, developments made in digital technology, use of advanced instruments and rising demand for specific blood constituents and source plasma are expected to boost the growth in the market. However, the growth may be restrained due to a single major factor which is risks involved in blood transfusion. Blood transfusion involves a high risk of transmission of diseases such as viral hemorrhagic fever, HIV and Hepatitis B, thereby limiting its use for serious cases.
| Report Attributes | Report Details |
|---|---|
| Report Name | Blood Preparation Market Research Report |
| Market Size in 2023 | USD 48.39 Billion |
| Market Forecast in 2032 | USD 83.15 Billion |
| Growth Rate | CAGR of 6.20% |
| Number of Pages | 196 |
| Key Companies Covered | AstraZeneca, Pfizer, Bristol-Myers, Celgene, GlaxoSmithKline, Shandong East Chemical, Sanofi-Aventis, Leo Pharma and Baxter Healthcare |
| Segments Covered | By product type, By Blood thinning agents and By Region |
| Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
| Base Year | 2023 |
| Historical Year | 2018 - 2022 |
| Forecast Year | 2024 - 2032 |
| Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
Global Blood Preparation Market: Regional Analysis
The largest share in the blood preparation market is held by North America and major growth can especially be seen in the U.S. This can be attributed to reasons such as an ultra-modern healthcare infrastructure, use of hi-technology for treatment purposes and strict control practiced by the FDA on the entire process of blood transfusion right from collection, preparation, and storage. Also, for favorable reimbursements for blood components, various other federal agencies are striving for health insurance portability standards to come into effect.
Asia Pacific is another major region showing a robust growth. Some of the major factors contributing to the growth in this region include rapid technological advancement and continual advancements made in the healthcare sector. Major countries showing growth in Asia Pacific include China, India, Japan and Australia. Also, a significant market share is contributed by regions such as Europe, Latin America and the Middle East and Africa.
Some of the major companies in the blood preparation market are:
By product type
By Blood thinning agents
By Region
FrequentlyAsked Questions
Blood preparation refers to the processing of donated blood into components such as plasma, platelets, and red blood cells for medical use.
The global blood preparation market is expected to be driven by the Market growth is driven by rising surgical procedures, increasing blood transfusion demand, and growing adoption of advanced blood processing and separation technologies.
According to study, the global blood preparation market size was worth around USD 48.39 Billion in 2023 and is predicted to grow to around USD 83.15 Billion By 2032.
The global blood preparation market is expected to grow at a Compound Annual Growth Rate (CAGR) of around CAGR 6.20% during the forecast period from 2024-2032.
The global blood preparation industry is projected to be challenged by Challenges include stringent regulatory standards, high equipment costs, and contamination risks. Skilled personnel shortages affect processing efficiency.
The Opportunities stem from rising transfusion needs, automation in blood banks, and demand for safer component separation, storage, and pathogen reduction solutions will offer significant growth opportunities in the blood preparation market.
Automation in component separation, pathogen reduction technologies, and advanced preservation solutions to extend shelf life are the emerging trends and innovations impacting the blood preparation market.
The global blood preparation market is expected to be led by North America during the forecast period.
Some of the prominent players operating in the global blood preparation market are; AstraZeneca, Pfizer, Bristol-Myers, Celgene, GlaxoSmithKline, Shandong East Chemical, Sanofi-Aventis, Leo Pharma and Baxter Healthcare and others.
The report explores crucial aspects of the blood preparation market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
HappyClients